Bevacizumab is safe in acute relapses of neuromyelitis optica.
Maureen A MealyKyong ShinGareth JohnMichael LevyPublished in: Clinical & experimental neuroimmunology (2015)
Bevacizumab is a safe add-on therapy to high-dose corticosteroids for NMO/NMO spectrum disease patients presenting with an acute relapse.